The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Challenging the mystique Connection. Deciphering cell-matrix interactions role in atherosclerosis and restenosis.

På svenska

Author

  • Vignesh Murugesan

Summary, in English

Atherosclerosis is the underlying cause for myocardal infarction, stroke and peripheral arterial disease, collectively referred to as cardiovascular diseases. These represent the major cause of death globally. Phenotypic modulationof vascular smooth muscle cells form a contractile to a synthetic state and subsequent migration into the intima, isone of the prime events that marks the genesis of atherosclerosis. To effectuate, cells are required to weaken the connection with their own basment membrane, a network of extracellular matrix molecules. This thesis exploresthe importance of Cell-ECM connections in atherosclerotic and restenostic settings using mice as a model. In detail, this thesis discusses the role of dystrophin and beta-sarcoglycan, two important components of theDystrophin-glycoprotein complex — one important way cells use to communicate with basement membranes.In paper I & II, we investigated whether beta-sarcoglycan has a role in the development of atherosclerotic plaquesand vascular injury induced neointima formation. Much to our surprise, we found that the absence of betasarcoglycanreduced advanced atherosclerotic plaque development, and in contrast, stimulated neo-intimalhyperplasia under conditions involving the presence or absence of an ApoE-deficient background, respectively.Under an atherosclerotic setting, the relative area of differentiated smooth muscle cells in the plaques wasincreased in beta-sarcoglycan deficient mice. Further, deficiency of beta-sarcoglycan decreased the weight ofvisceral adipose tissue and reduced the size of both brown and white adipocytes.In paper III, we utilized mdx mice to determine if there is also a role for dystrophin in the process of atheroscleroticplaque development. We obtained similar results as in the study with sarcoglycan deficient mice; the mdx miceexhibited a significant attenuation of advanced atherosclerotic plaque growth with an increase in the relative areaof differentiated smooth muscle cells in their plaques. A reduction in T-cell content in these plaques and an overallreduction in systemic inflammation was also observed.In paper IV, we observed that actin dynamics influence genes important for regulation of VSMC phenotypes andfound dystrophin to be significantly increased and decreased by actin polymerization and depolymerization,respectively. A significant downregulation of dystrophin was observed under the influence of vascular injury.To summarize, this thesis uncovers the important influence of a functional CELL-ECM linkage mediated bydystrophin and beta-sarcoglycan on vascular lesion development.

Publishing year

2017

Language

English

Document type

Dissertation

Publisher

Lund University: Faculty of Medicine

Topic

  • Cardiac and Cardiovascular Systems

Keywords

  • Dystrophin glycoprotein complex, beta-sarcoglycan, dystrophin, Plaque, vascular smooth muscle cells, atherosclerosis, restenosis

Status

Published

Research group

  • Vessel Wall Biology

ISBN/ISSN/Other

  • ISBN: 978-91-7619-500-0

Defence date

1 September 2017

Defence time

13:00

Defence place

Segerfalksalen, BMC, Sölvegatan 17, Lund

Opponent

  • Ilze Bot (assistant professor)